期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
基于嗅觉受体激活关系模拟的气味感知预测
1
作者 左敏 胡静珺 +3 位作者 颜文婧 王瑞东 张青川 范大维 《中山大学学报(自然科学版)(中英文)》 CAS CSCD 北大核心 2024年第1期86-95,共10页
气味分子与嗅觉受体相互作用是引起气味感知的重要环节,对于揭示气味感知机制具有重要意义。然而,获得气味分子与人类嗅觉受体激活关系的实验性结果耗时耗力,且目前可用的激活关系数据数量不足以支持智能气味感知研究。因此,本研究构建... 气味分子与嗅觉受体相互作用是引起气味感知的重要环节,对于揭示气味感知机制具有重要意义。然而,获得气味分子与人类嗅觉受体激活关系的实验性结果耗时耗力,且目前可用的激活关系数据数量不足以支持智能气味感知研究。因此,本研究构建了嗅觉受体蛋白质关系网络,并提取特征来训练气味分子-嗅觉受体激活关系预测模型。在气味感知预测中综合考虑气味分子特征和嗅觉受体蛋白激活模拟关系,实现了对人类气味感知的高精度回归预测。实验结果表明,融合气味分子-嗅觉受体激活关系的人类气味感知预测相关度指标为0.94,明显优于现有的气味感知预测模型。此外,研究还在预测基础上总结了气味分子-嗅觉受体激活-气味感知模式。本研究为气味感知预测引入了可观测的嗅觉受体激活机制特征,为深入探索和理解气味感知机制提供了新思路。 展开更多
关键词 分子特征提取 蛋白质特征提取 嗅觉受体激活预测 气味感知预测 图卷积 机器学习
下载PDF
基于序列的G蛋白偶联受体-药物相互作用预测研究 被引量:1
2
作者 丁林松 郑宇杰 《计算机科学》 CSCD 北大核心 2015年第8期75-77,111,共4页
准确预测G蛋白质偶联受体(GPCR)是否与药物(Drug)相互作用是新药开发的关键步骤之一。从时间和费用方面来说,通过生物实验的方法来确定GPCR-Drug是否相互作用的代价是昂贵的。因此,直接从蛋白质序列出发预测GPCR-Drug的相互作用具有重... 准确预测G蛋白质偶联受体(GPCR)是否与药物(Drug)相互作用是新药开发的关键步骤之一。从时间和费用方面来说,通过生物实验的方法来确定GPCR-Drug是否相互作用的代价是昂贵的。因此,直接从蛋白质序列出发预测GPCR-Drug的相互作用具有重要的意义。提出了一种基于序列的GPCR-Drug相互作用预测方法:从蛋白质序列抽取进化信息特征;对药物抽取指纹特征;基于上述两种特征,使用基于证据理论的K近邻算法进行分类预测。在标准数据集上的实验结果表明了所述方法的有效性。 展开更多
关键词 G蛋白质偶联受体 药物 特征抽取 预测
下载PDF
机器学习在抗乳腺癌候选药物预测模型中的应用
3
作者 陈枭宇 陈骅桂 随力 《软件导刊》 2022年第12期46-52,共7页
为了提高抗乳腺癌候选药物特征筛选与模型预测的准确性,提出一种新的多种组合特征筛选方法对抗乳腺癌候选药物——雌激素受体α亚型(ERα)的分子描述符进行特征筛选,并根据筛选的分子描述符构建化合物活性预测(QSAR)模型。采用1DCNN算... 为了提高抗乳腺癌候选药物特征筛选与模型预测的准确性,提出一种新的多种组合特征筛选方法对抗乳腺癌候选药物——雌激素受体α亚型(ERα)的分子描述符进行特征筛选,并根据筛选的分子描述符构建化合物活性预测(QSAR)模型。采用1DCNN算法模型预测化合物活性,该模型的RMSE、MAE、MAPE评价指标值分别为0.40、0.41和0.08,相比传统随机森林和支持向量机算法的预测效果提高了10%。基于多种组合的特征筛选方法和1DCNN模型预测为药物化合物特征筛选与活性预测提供了新思路,后续可用于其他药物化合物的预测。 展开更多
关键词 机器学习 乳腺癌 激素受体α亚型 药物预测 组合特征筛选 1DCNN
下载PDF
Etiological characteristics and treatment of tardive dyskinesia
4
作者 Zhe Li Xueli Sun Che Zhou 《Neural Regeneration Research》 SCIE CAS CSCD 2006年第6期549-552,共4页
OBJECTIVE : The pathogenesis of tardive dyskinesia (TD) is complicated and uncertain, Thus, there is not any effective treatment for it. The psychiatrists pay more and more attention to TD, which lasts for a long t... OBJECTIVE : The pathogenesis of tardive dyskinesia (TD) is complicated and uncertain, Thus, there is not any effective treatment for it. The psychiatrists pay more and more attention to TD, which lasts for a long time and is difficult to treat. DATA SOURCES: A computer-based online search of Medline database was undertaken to identify articles about the feature of etiology and the progression of treatment for TD published in English by using the keywords of "rD, etiology, pathogenesis" and "TD, therapy, drug treatment". Meanwhile, Chinese articles about the feature of etiology and the progression of treatment for TD were searched in Wanfang database and China journal full-text database, and the keywords were "TD, etiology, pathogenesis" and "TD, therapy, drug Treatment" in Chinese. STUDY SELECTION: Articles met the following inclusion criteria were selected in this paper. Inclusion criteria: (1) Researches of randomized blind control design, before and after control design and retrospective. (2) Researches of the feature of etiology and the progression of treatment for TD. Exclusion criteria: the repetitive researches and individual reports. DATA EXTRACTION : Totally 65 articles related the feature of etiology and the progression of treatment for TD of randomized blind control design, before and after control design and retrospective studies were collected, and 53 of them were accorded with the inclusion criteria. Of the 12 excluded ones, 8 were concerning with genetics, 4 were repetitive researches. DATA SYNTHESIS : The feature of etiology for TD includes:(1) Hypothesis of dopamine receptor super-sensitivity: The dopamine receptor is persistently blocked, so it will result in functional disorder in CNS, and then TD may take place. (2)) Hypothesis of neuronal degeneration: The concentration of aminosuccinic acid and glutamic acid will increase after the antipsychotic used for a long time and this will result in neuronal degeneration through glutamic acid receptor in the postsynaptic membrane; meanwhile with free radical, the nerve cells of corpus striatum may degenerate and become necrosis. (3) Sex and age: The females and gerontal patients are liability to the TD disease. It is may related to the lower estrogen. (4) Molecule heredity: TD may association with the dopamine and 5-HT receptor gene polymorphism. (5) Other theories: Hypofunction of γ-amino-butyri acid (GABA), hypothesis of noradrenaline 5-serotonin and nutrition metabolism can cause TD disease. Treatlent for TD: (1) Dopamine receptor agonist: The therapeutic effect is not satisfactory, especially for gerontism females. (2) Oxygen free radical scavenger: As represent of vitamin E, it can clear out free radicals and reduce the potential cytotoxic effect of free radicals. (3) Calcium channel blocker: This maybe related to block calcium ions releasing from muscle cells and inhibit muscle convulsion; therefore, it can be used for symptomatic treatment. (4) GABA receptor agonist: It is more effective for the prominent dysmyotonia than dancing slowly symptom. (5) Antipsychotic: There is some therapeutic effect with ciozapine, but the effect will reduce because of the age growing up and the symptom exacerbating. (6) Other therapies: Valproate sodium, cyproheptadine, melatonin, branched chain amino acid, ahalysantinfarctasum, electric acupuncture and injection ad acumen, traditional Chinese drug have a certain effects on TD. Prevention of TD: The serum creatine phosphokinase (CPK) combined with symptoms should be checked regularly so as to early discovery TD. CONCLUSION : (1) Etiology of TD: The hypothesis of dopamine receptor super-sensitivity is denyed; the hypothesis of neuronal degeneration is approved in academic circles; the sex and age is a finding of generally received; but the dopamine and 5-HT receptor gene polymorphism, hypofunction of GABA, noradrenaline, 5-serotonin and nutrition metabolism cannot explain the pathogenesis of TD. (2) Treatment for TD: The therapeutic effect of dopamine receptor agonist is not satisfactory; the oxygen free radical scavenger maybe effective; calcium channel blocker maybe used for symptomatic treatment; GABA receptor agonist maybe more effective for the prominent dysmyotonia than dancing slowly symptom; the consequence of antipsychotic is discrepancy; other therapies maybe use to adjunctive therapies. (3) As far as prevention of TD is concerned, and the serum CPK combined with symptoms should be checked regularly so as to early discovery TD. 展开更多
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部